CES 2019 Pitch Competition Featuring Shark Tank’s Daymond John Presented by CTA Foundation, AARP
The first annual CES Pitch Competition to highlight technology creating social connection was announced today by the Consumer Technology Association (CTA) Foundation and AARP. Kicking off the inaugural event will be special guest emcee Daymond John, the AARP Brand Ambassador who is the Founder and CEO of $6 billion global lifestyle brand, FUBU, and Co-Star of ABC’s Emmy Award winning business show, Shark Tank.
The Consumer Technology Association (CTA) Foundation – a national foundation with the mission to link seniors and people with disabilities with technologies to enhance their lives – invites CES 2019 attendees to participate in selecting the winners by in-person audience vote. The pitch event is sponsored by AARP Innovation Labs which engages with startups to transform markets and change lives.
CES 2019 Pitch Competition
Because social isolation has a comparable health impact to smoking 15 cigarettes a day, the CES 2019 Pitch Competition will highlight technologies that could help increase personal connection. This issue impacts people of all ages, including the 115 million Americans age 50-plus whose numbers are increasing at the fastest rate. The 50-plus demographic will increase to 132 million people in 2030. This age group also has significant buying power, with Americans age 50 and over comprising a Longevity Economy that generates more than $7.6 trillion in annual economic activity.
The pitch event will take place at CES 2019, Thursday, January 10, 2019, at 10:00 AM PT at the Start Up Stage in Eureka Park at the Sands.
“Helping to drive the development of innovative new products and services that focus on the interests and needs of people age 50-plus is an important element of AARP’s mission,” said AARP CEO Jo Ann Jenkins. “The CTA Foundation Pitch Competition will help deliver new solutions to a large and, so far, underserved market and spotlight a key opportunity that other businesses are missing out on.”
“CES 2019 will feature enormous technological innovation across the show to help people stay connected and living healthy, independent lives at work, home and play,” said Stephen Ewell, executive director of the CTA Foundation.
The eight companies invited to pitch represent a diverse take on using technology to create social connections. These include:
- Fishball – Clip-on lens to turn iPhone into a 360˚ photo and video camera
- Glowbl – Video conferencing solution allowing multiple types of content to be shared at once
- GoSun – Solar stove with fuel-free technology that is low-cost, portable, versatile and durable
- House of Haptics – Wearable bracelet to send human touch over distances
- Language Hero – Smart language training app that enables people who speak different languages to quickly and efficiently communicate with each other via video chat
- StoryUp Healium – VR solution using EEG feedback to reduce stress and provide virtual travel opportunities
- Tikaway – “Connected” glasses that provide hands-free video collaboration
- Waverly Labs – Earpiece that translates 15 languages and 42 dialects and also offers music streaming and voice calls
Eureka Park Accessibility Contest
The CTA Foundation also announced the winners of its fourth annual Eureka Park Accessibility Contest. The winners of this contest were selected from a pool of Extreme Tech Challenge entries based on their ability to benefit older adults and people with disabilities. The five winners each receive a booth in Eureka Park at CES 2019 and a $2,500 prize. The CES 2019 Eureka Park Accessibility Contest winners are:
To learn more about accessibility technology at CES, visit https://www.ces.tech/Topics/Health-Wellness/Accessibility.aspx
Click here to learn more about the CES 2019 Pitch Competition.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
A Better Way to Earn Interest on Digital Assets18.1.2019 01:00 | Pressemelding
Cred, the leading provider of crypto borrowing and lending with over $300 million in credit facilities, today announced the launch of CredEarn* on the Uphold platform. CredEarn allows Uphold customers to lend their crypto and fiat assets to Cred and receive up to 10% of annualized interest. “We’re thrilled to offer consumers the opportunity to earn interest on their digital assets and fiat currencies,” said Dan Schatt, Co-founder and President of Cred. “In a bear market, customers can benefit from the liquidity they receive when obtaining a fixed amount of interest in USD or Stablecoin. In a bull market, customers also benefit by receiving the full upside on the amount of crypto they originally committed.” CredEarn customers can commit to a six-month term with the ability to rollover assets for additional periods. No account minimum is needed and interest is paid out in U.S. Dollars or Stablecoin every three months on Uphold. The principal is paid back in the fiat or crypto amounts tha
Servier and Taiho Oncology Present Latest LONSURF® (trifluridine/tipiracil) Data at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)17.1.2019 23:45 | Pressemelding
Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today that the safety and efficacy data in the gastrectomy patient subgroup of the global Phase III trial TAGS evaluating LONSURF® (trifluridine/tipiracil, TAS-102) in patients with metastatic gastric cancer (mGC) are consistent with the overall study results published in The Lancet Oncology. These data were highlighted in an oral presentation at the ASCO 2019 Gastrointestinal Cancers Symposium (ASCO-GI) on Thursday 17 January. In TAGS, 221 (44%) of the 507 randomized mGC patients had undergone prior gastrectomy (147 LONSURF, 74 placebo), which is reflective of the real-world patient population diagnosed with mGC. The results confirmed that trifluridine/tipiracil prolonged survival versus placebo regardless of prior gastrectomy. The overall results of TAGS demonstrated that patients treated with oral trifluridine/tipiracil showed a clinically meaningful and statistically s
ISACA Announces 2019 Slate of Events for Business Technology Professionals Around the Globe During its 50th Anniversary Year17.1.2019 19:24 | Pressemelding
ISACA, a global association serving technology audit, assurance, governance and cybersecurity professionals, celebrating its 50th anniversary in 2019, announced its annual event schedule, which includes learning opportunities focused on emerging technologies, innovation, best practices and professional development. Disruptive technologies over the last 50 years and in the future of business enterprise, and the evolution of technology careers and ISACA professions, will be featured in conjunction with the ISACA anniversary year at nearly every venue. ISACA’s growing Cybersecurity Solution Portfolio, including the CSX Training Platform and the CMMI Cybermaturity Platform, will be highlighted in new conferences in 2019, which will include events in North America and Europe. The 2019 CACS conferences, set for North America, Europe, Asia, Africa, the Oceania region and Latin America, will offer educational sessions in audit and assurance, big data, risk management, governance and more. All
HighLife Closes a €32 Million Round B Financing17.1.2019 17:25 | Pressemelding
HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which includes regulatory approval trials in Europe to obtain the CE mark and a first clinical trial in the U.S. via an Early Feasibility Study (EFS). The Series B round was co-led by U.S. Venture Partners (“USVP”) and Andera Partners, with Sectoral Asset Management and Jose Calle Gordo, Chairman of the company, joining the round. Sofinnova Partners, which led the Series A round, continues to support the company and participated in this latest round of financing. Bryan Garnier & Co (Paris) acted as private placement agent for this financing. “I am very pleased to announce the closing of the Ser
The Brightline™ Initiative, led by Project Management Institute, to Support The Economist Davos Panel17.1.2019 15:00 | Pressemelding
The Brightline™ Initiative, a coalition dedicated to helping executives bridge the gap between strategy design and delivery, along with Project Management Institute is hosting The Economist Events panel discussion entitled “Humans 2.0: Designing and Implementing a Future Proof Strategy.” In line with Davos’ overarching theme, “Globalization 4.0: Shaping a Global Architecture in the Age of the Fourth Industrial Revolution,” panelists will discuss how business leaders can harness the power of people to adapt and implement corporate strategies and grapple with the effects of disruptive technologies. This topic is of particular interest to PMI, the leading member of Brightline, given how this wave of disruption calls for organizations to rely on successful implementation of new strategies at unprecedented scope and speed to meet market demands. “As a coalition committed to moving from idea to strategy implementation to results, we’re delighted to partner with The Economist Events to bring
MSCI Schedules Investor Conference Call to Review Fourth Quarter and Full Year 2018 Results17.1.2019 14:00 | Pressemelding
MSCI Inc. (NYSE:MSCI), a leading provider of indexes and portfolio construction and risk management tools and services for global investors, today announced it will release its results for the fourth quarter and full year 2018 on Thursday, January 31, 2019. MSCI's senior management will review the fourth quarter and full year 2018 results on Thursday, January 31, 2019 at 11:00 AM Eastern Time. To listen to the live event, visit the events and presentations section of MSCI's Investor Relations homepage, http://ir.msci.com/events.cfm, or dial 1-877-376-9931 conference ID: 3474708 within the United States. International callers dial 1-720-405-2251 conference ID: 3474708. The earnings release and related investor presentation used during the conference call will be made available on MSCI's Investor Relations homepage. An audio recording of the conference call will be available on our Investor Relations website, http://ir.msci.com/events.cfm, beginning approximately two hours after the conc